Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer

Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254 Clark, 2013, Bladder cancer, J Natl Compr Cancer Netw, 11, 446, 10.6004/jnccn.2013.0059 Gore, 2010, Use of radical cystectomy for patients with invasive bladder cancer, J Natl Cancer Inst, 102, 802, 10.1093/jnci/djq121 Gakis, 2013, ICUD-EAU International Consultation on Bladder Cancer 2012. Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder, Eur Urol, 63, 45, 10.1016/j.eururo.2012.08.009 Mitin, 2016, Long-term outcomes among patients who achieve complete or near-complete responses after the induction phase of bladder-preserving combined-modality therapy for muscle-invasive bladder cancer: a pooled analysis of NRG Oncology/RTOG 9906 and 0233, Int J Radiat Oncol Biol Phys, 94, 67, 10.1016/j.ijrobp.2015.09.030 Weir, 2014, Evaluation of North American Association of Central Cancer Registries’ (NAACCR) data for use in population-based cancer survival studies, J Natl Cancer Inst Monogr, 2014, 198, 10.1093/jncimonographs/lgu018 Efstathiou, 2012, Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience, Eur Urol, 61, 705, 10.1016/j.eururo.2011.11.010 Shen, 2016, Therapeutic substitutions in the midst of new technology diffusion: the case of treatment for localized prostate cancer, Soc Sci Med, 151, 110, 10.1016/j.socscimed.2016.01.016 Cary C, Odisho AY, Cooperberg MR. Variation in prostate cancer treatment associated with population density of the county of residence. Prostate Cancer Prostat Dis. In press. http://dx.doi.org/10.1038/pcan.2015.65 Barocas, 2014, Racial variation in the quality of surgical care for bladder cancer, Cancer, 120, 1018, 10.1002/cncr.28520 Schmid, 2016, Racial differences in the surgical care of medicare beneficiaries with localized prostate cancer, JAMA Oncol, 2, 85, 10.1001/jamaoncol.2015.3384 Boorjian, 2013, Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer, J Urol, 190, 55, 10.1016/j.juro.2013.01.010 Novara, 2009, Complications and mortality after radical cystectomy for bladder transitional cell cancer, J Urol, 182, 914, 10.1016/j.juro.2009.05.032 Murthy, 2004, Participation in cancer clinical trials: race-, sex-, and age-based disparities, JAMA, 291, 2720, 10.1001/jama.291.22.2720 Lewis, 2003, Participation of patients 65 years of age or older in cancer clinical trials, J Clin Oncol, 21, 1383, 10.1200/JCO.2003.08.010 Donsky, 2014, Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries, Urol Oncol, 32, 10.1016/j.urolonc.2013.04.010 Shapiro M, Chen Q, Huang Q, et al. Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer. JAMA Surg. 2015. Booth, 2014, Perioperative chemotherapy for muscle-invasive bladder cancer: a population-based outcomes study, Cancer, 120, 1630, 10.1002/cncr.28510 Froehner, 2014, Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy, Eur Urol, 66, 987, 10.1016/j.eururo.2014.07.046